Phase Forward Acquires Part Of Covance’s Business
Phase Forward has acquired Interactive Voice and Web Response Services (IVRS/IWRS) business of Covance. The company purchased the Covance business unit for $10m in cash. Reportedly, as part
Swedish Orphan Biovitrum (Sobi) has received a complete response letter from the US Food and Drug Administration (FDA) regarding its biologics licence application for nanoencapsulated sirolimus plus pegadricase (NASP), an investigational therapy intended for adults with uncontrolled gout.